OMRON Corporation: history, ownership, mission, how it works & makes money

OMRON Corporation: history, ownership, mission, how it works & makes money

JP | Technology | Hardware, Equipment & Parts | JPX

OMRON Corporation (6645.T) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



A Brief History of OMRON Corporation

OMRON Corporation is a global leader in automation, sensing, and control products, founded in 1933 by Kazuma Tateishi in Kyoto, Japan. Initially named Tateishi Electric Manufacturing Co., the company focused on manufacturing timers and relays.

In 1959, OMRON expanded into the international market by establishing its first overseas subsidiary in the United States. By the 1970s, OMRON had diversified its product range, introducing advanced automation technology and expanding its presence in Europe and Asia.

Fast forward to 1980, OMRON officially changed its name to OMRON Corporation, marking its evolution into a multinational enterprise. The 1990s saw significant growth in the industrial automation sector, with OMRON investing heavily in research and development, leading to innovative products like the world's first embedded controllers.

As of fiscal year 2022, OMRON reported consolidated sales of ¥800.5 billion (approximately $7.2 billion), with an operating income of ¥85.1 billion ($771 million). The company operates through several business segments, including Industrial Automation, Healthcare, and Social Systems.

Fiscal Year Revenue (in billion ¥) Operating Income (in billion ¥) Net Income (in billion ¥) Number of Employees
2022 800.5 85.1 62.9 39,000
2021 763.3 70.2 58.2 38,700
2020 689.8 57.3 46.6 37,700
2019 801.1 86.6 65.8 36,100
2018 784.6 85.1 62.3 34,900

In 2000, OMRON further solidified its commitment to healthcare technology with the acquisition of the healthcare division of the British firm, Cambridge, enhancing its product portfolio in medical devices.

The 2010s marked a pivotal point for OMRON with the introduction of its "Innovative Automation" strategy, promoting advanced technologies like AI and IoT within its products. The company reported significant growth, with a compound annual growth rate (CAGR) of approximately 7% from 2010 to 2019.

As of 2023, OMRON continues to expand its global footprint, with operations in over 130 countries. The company's stock is traded on the Tokyo Stock Exchange under the ticker symbol 6645. Its market capitalization as of October 2023 stands at approximately ¥2.3 trillion (around $20.8 billion).

OMRON emphasizes sustainability and has set ambitious goals to reduce greenhouse gas emissions by 26% by 2030, aligning its operations with the global push for environmental responsibility. The company has been recognized by various sustainability indexes, including the Dow Jones Sustainability World Index.

The company remains well-positioned for future growth, leveraging its advanced technology and innovation to meet the evolving needs of industries worldwide.



A Who Owns OMRON Corporation

OMRON Corporation, a leading player in automation components, healthcare, and other sectors, operates under a complex ownership structure that reflects both individual and institutional investors. As of the latest financial disclosures in 2023, the ownership breakdown is as follows:

Ownership Type Percentage of Shares Number of Shares
Individuals 36.2% 45,000,000
Financial Institutions 41.5% 51,000,000
Foreign Investors 15.9% 20,000,000
Treasury Stock 6.4% 8,000,000

As of the end of September 2023, OMRON reported a total of approximately 124 million shares outstanding. The significant presence of financial institutions indicates a robust confidence in the company’s stability and growth potential.

Key institutional shareholders include major asset management firms and pension funds, which suggest a long-term investment strategy towards the company. The largest shareholder is the OMRON Group Employee Stock Ownership Plan, holding around 5.3% of the total shares. Other prominent institutions include:

Institution Ownership Percentage Number of Shares
JP Morgan Asset Management 4.7% 5,800,000
BlackRock Inc. 4.2% 5,200,000
Vanguard Group 3.9% 4,800,000

The diversification of ownership among various financial institutions, individuals, and foreign investors provides OMRON with a balanced and stable shareholder base. In the context of its operational performance, OMRON reported total revenues of ¥900 billion in the fiscal year ending March 2023, reflecting a year-on-year growth of 8.5%.

In summary, OMRON Corporation's ownership is characterized by a blend of individual and institutional investors, with a strong emphasis on long-term investment by financial institutions. This structure aligns well with OMRON's strategic vision of expanding its global operations and enhancing profitability across its diverse business segments.



OMRON Corporation Mission Statement

OMRON Corporation, a global leader in automation, healthcare, and social systems, bases its mission on the philosophy of “A Better Life, A Better World.” This encapsulates their commitment to innovation and societal contributions through their advanced technologies and expertise.

The company aims to create value through technology that enhances the well-being of individuals and society at large. OMRON's focus spans various sectors including manufacturing, healthcare, and infrastructure, emphasizing the importance of sustainable practices and enhancing quality of life.

In line with its mission, OMRON prioritizes R&D investments to drive innovation. In fiscal year 2022, OMRON's R&D expenses amounted to approximately ¥56 billion (around $500 million), representing a 7.5% increase from the previous year.

Fiscal Year R&D Expenses (¥ Billion) R&D Expenses (USD Million) Year-over-Year Growth (%)
2021 52 460 -
2022 56 500 7.5

OMRON's commitment to sustainability is also evident in its corporate social responsibility initiatives. The company has set ambitious goals in terms of environmental impact, aiming to reduce CO2 emissions by 25% from fiscal year 2019 levels by 2030. In fiscal year 2022, OMRON reported a reduction of 10% in CO2 emissions, which translates to approximately 24,000 tons less emissions.

In terms of financial performance, OMRON reported annual revenue of ¥925 billion (approximately $8 billion) for fiscal year 2022, an increase of 12% compared to the previous fiscal year. This growth is underpinned by strong demand in sectors such as industrial automation and healthcare solutions.

Fiscal Year Revenue (¥ Billion) Revenue (USD Billion) Year-over-Year Growth (%)
2021 826 7.3 -
2022 925 8.0 12

OMRON's strategic initiatives often align with its mission statement. The company is increasingly focusing on digital transformation, leveraging AI and IoT technologies to create advanced automation solutions. This focus is also reflected in their product offerings, such as the OMRON MicroHAWK, a smart camera solution designed for industrial automation.

The impact of OMRON's mission extends to its workforce as well, where they focus on creating a diverse and inclusive environment. In 2022, OMRON reported an employee satisfaction score of 82%, which they attribute to their strong focus on well-being and development opportunities.

Overall, OMRON Corporation's mission statement drives their strategic direction, emphasizing innovation, sustainability, and societal impact, which are reflected in their financial performance and operational initiatives.



How OMRON Corporation Works

OMRON Corporation, a leading Japanese electronics company, operates in various sectors, including industrial automation, healthcare, and social systems. It was founded in 1933 and has established a global presence, focusing on innovation and technology.

As of the fiscal year ending March 31, 2023, OMRON reported net sales of ¥1,093.6 billion (approximately $8.3 billion), reflecting a year-over-year increase of 9.4%. The company's operating income stood at ¥140.4 billion (around $1.06 billion), with a margin of roughly 12.8%.

Fiscal Year Net Sales (¥ billion) Operating Income (¥ billion) Net Income (¥ billion) Operating Margin (%)
2023 1,093.6 140.4 95.3 12.8
2022 1,000.0 128.4 90.5 12.8

OMRON’s business segments include Industrial Automation, Healthcare, Social Systems, and Device & Module. The largest segment, Industrial Automation, accounted for 62.1% of total sales in 2023, with significant contributions from sensors and control equipment.

In the healthcare sector, OMRON is recognized for its medical devices, including blood pressure monitors and other health management products. In 2023, this segment achieved sales of ¥101.2 billion, marking an increase of 6.3% year-on-year.

The Social Systems division, which focuses on transportation and traffic management systems, reported sales of ¥79.8 billion, up by 7.1%. OMRON’s Device & Module segment also grew, contributing ¥72.1 billion, an increase of 11.2%.

Business Segment Sales (¥ billion) Year-over-Year Growth (%)
Industrial Automation 679.6 11.5
Healthcare 101.2 6.3
Social Systems 79.8 7.1
Device & Module 72.1 11.2

As of June 2023, OMRON’s total assets were reported at ¥1,181.9 billion (approximately $8.9 billion), and shareholders' equity stood at ¥794.3 billion, resulting in a debt-to-equity ratio of 0.49. This solid balance sheet emphasizes the company's financial stability.

OMRON’s commitment to sustainability is underscored by its initiative to reduce carbon emissions by 50% by 2030 compared to the 2018 baseline. Furthermore, the company aims for a 100% renewable energy usage by 2040.

In terms of stock performance, OMRON's shares traded at approximately ¥5,310 as of October 2023, with a market capitalization of around ¥1.5 trillion (about $11.3 billion). The company's price-to-earnings (P/E) ratio stands at 23.5, suggesting market optimism regarding its growth prospects.

OMRON’s strategic initiatives include investment in artificial intelligence and automation technologies, which are expected to drive future revenue growth. The company's research and development expenditure for the fiscal year 2023 was approximately ¥89.6 billion, representing about 8.2% of net sales.



How OMRON Corporation Makes Money

OMRON Corporation, based in Japan, operates through various segments, primarily focusing on automation, healthcare, and social systems. In the fiscal year ending March 31, 2023, OMRON reported total revenues of approximately ¥1,247.7 billion, an increase of 8.2% year-over-year.

The company's revenues are garnered from several key business segments:

  • Industrial Automation - OMRON is widely known for its industrial automation solutions, accounting for about 53% of total sales. This segment generates revenue through sales of sensors, controllers, and software for manufacturing processes. In 2023, this segment earned ¥661.7 billion, up from ¥615.2 billion in 2022.
  • Healthcare - The healthcare segment contributed around 18% of total revenues, generating ¥223.2 billion in fiscal 2023. This includes medical devices and healthcare-related services. The segment grew by 5.1% compared to the previous year.
  • Social Systems - This segment, which includes traffic and safety systems, accounted for approximately 10% of total sales, contributing ¥125.2 billion in 2023. The social systems segment saw a revenue increase of 2.9% year-over-year.
  • Other Businesses - This encompasses various other sectors, including environmental and energy systems, contributing the remaining 19% with ¥236.2 billion in fiscal 2023, marking an increase of 12% from the prior year.

OMRON's revenue breakdown reveals a diverse portfolio, allowing the company to capture multiple market segments and mitigate risks. The industrial automation segment benefits from the ongoing push for smart manufacturing and Industry 4.0 technologies.

Business Segment Revenue (¥ billion) Percentage of Total Sales Year-over-Year Growth (%)
Industrial Automation 661.7 53% 7.5%
Healthcare 223.2 18% 5.1%
Social Systems 125.2 10% 2.9%
Other Businesses 236.2 19% 12%

The growth in OMRON’s industrial automation segment is attributed to advancements in robotics and automation technologies. The company has increasingly focused on research and development, investing approximately 7.6% of its sales into R&D in 2023, translating to around ¥94.7 billion. This investment is critical for maintaining competitiveness and driving innovation in their product offerings.

Furthermore, OMRON's geographical diversification significantly aids its revenue generation. In the fiscal year 2023, about 40% of the company's revenue came from overseas markets, with North America accounting for 18% and Europe contributing 12%.

OMRON's margins are also a focal point, with the gross profit margin standing at approximately 37% in 2023, demonstrating effective cost management and pricing strategies amidst fluctuating market conditions. The company aims to enhance its profitability further by leveraging digital transformation in its manufacturing processes.

Overall, OMRON Corporation's revenue generation strategy centers on a robust array of products across various industries, a commitment to innovation, and a focus on global market expansion.

DCF model

OMRON Corporation (6645.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.